5 employees
Revel Pharmaceuticals develops therapeutics for multiple diseases of aging including osteoarthritis, kidney, and complications of diabetes.
2019
$8.4M
from 1 investors over 1 rounds
Revel Pharmaceuticals raised $8.4M on March 17, 2022
Investors: KIZOO